Octave is collaborating with Quest Diagnostics to expand access to its MSDA blood test, used to measure disease activity in ...
Although this is one route for a diagnostic device, securing FDA approval allows Cleveland Diagnostics to send IsoPSA kits ...
The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...
Verywell Health on MSN
We Asked a Doctor Who Actually Needs a Vitamin D Supplement in the Winter
A doctor explains who truly needs a vitamin D supplement in the winter, how to tell if you're deficient, and when ...
StockStory.org on MSN
Testing & diagnostics services stocks Q3 recap: Benchmarking NeoGenomics (NASDAQ:NEO)
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...
Optiscan will carry out a Perth-based imaging study of head and neck cancers, using its novel precision surgical and ...
Neonatal Toxicology Market to reach USD 931.7 Mn by 2035 at 10.9% CAGR, driven by rising prenatal substance exposure and ...
Looking for the best tech gifts for everyone this holiday season? Check out our list of this year’s latest tech, from ...
Three Planned Parenthood Federation of America clinics in Florida are fighting back after Florida’s health agency ordered them to stop performing second-trimester abortions because they lacked proper ...
Hims & Hers obtains YourBio's microsampling tech, which the firm said will speed its efforts to improve blood collection, including outside traditional clinical settings.
This is Optimizer, a weekly newsletter sent every Friday from Verge senior reviewer Victoria Song that dissects and discusses ...
Luxury Columnist on MSN
The future of preventative healthcare: Superpower biomarker testing
We tried out one of the most advanced baseline diagnostic panels available – here’s what we discovered about our health […] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results